All News

During an interview, Joseph Shields of TransparencyRx discusses the PBM legislation that is expected to move forward in Congress in the next few months.

Albert Dahan, MD, PhD, professor of anesthesiology at Leiden University Medical Center, talks about the first-in-class dual-NMR agonist cebranopadol.

Chijioke Bennett, executive director of clinical development at Novavax, discusses how health care providers can increase awareness around COVID-19 vaccination and how to help patients overcome vaccine hesitancy.

Timothy Mackey, MAS, PhD, discusses the dangers associated with sourcing GLP-1s from illegal online pharmacies and the key role pharmacists play in warning patients.

Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, discusses the implications of a potential FDA approval of MDMA-assisted therapy for PTSD.

Sharing concrete steps and suggestions can help ease the way for patients looking to transition to a more healthful lifestyle.

Health care professionals all agree that a healthy diet is the foundation of cardiovascular and cardiometabolic health, but follow-through on the population level is lacking.

Losing even 5% of body weight can improve comorbid conditions and other health complications for individuals with overweight and obesity.

Erin Albert, Vice President of Pharmacy Relations and Chief Privacy Officer at Mark Cuban Cost Plus Drug Company, PBC, discussed the changing landscape regarding prescription drug pricing.

Jon Minkin, Enterprise Account Executive at NimbleRx and pharmacy technology expert, discussed how his company can help independent pharmacies unlock revenue opportunities.

Shivang Joshi, MD, MPH, RPh, FAHS discusses how pharmacists can utilize their role as the most accessible health care professional to provide care to patients with migraine, as well as resources to enhance awareness and education.

Shivang Joshi, MD, MPH, RPh, FAHS, headache specialist neurologist at Community Neuroscience Services, debunks common migraine myths.

Patrick Alonso, PharmD, CPh, discusses how pharmacists' skills are underutilized and how they can help support men’s health.

Patrick Alonso, PharmD, CPh, provides some tips for men looking to improve their overall mental health.

Patrick Alonso, PharmD, CPh, discusses how pharmacists can support men dealing with mental health issues and lifestyle changes he recommends to male patients to improve overall health.

Patrick Alonso, PharmD, CPh, owner and manager of BlueZone Health Care Advocates and co-host of the Men’s Health Unscripted podcast, talks about how health care providers can build trust with male patients and what screenings men at different ages should be having.

Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, discusses how some of the concern’s raised by the panel can inform future psychedelic research.

Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, talks about some of the problems he saw during the Psychopharmacologic Drugs Advisory Committee meeting.

Savannah Roberts Clary, PharmD, BCPS, CPGx, a clinical pharmacist with Aegis Sciences Corporation, talks about the dangers of tianeptine and how pharmacists can help warn the public about the potential hazards of tianeptine.

Pharmacists must take a multifaceted approach to educating patients on sun safety that extends beyond sunscreen counseling, according to Colleen McCabe, PharmD, BCOP.

Colleen McCabe, PharmD, BCOP, emphasizes the importance of a proactive and tailored approach for pharmacists educating patients on skin cancer risks specific to their communities.

The market is sensitive to both upstream and downstream pressures that impact drug pricing.

The specialty drug market has exploded, and will continue to grow across sectors such as oncology and neurology.

A lack of clarity around certain provisions of the Inflation Reduction Act has presented challenges to payers.

Understanding the goals of each party is the first step to a successful collaboration.

Collaboration between health system specialty pharmacists and pharmaceutical manufacturers can benefit patients in the long run.

Addressing requirements around FDA interchangeability designations can increase the adoption of biosimilar substitutions at the pharmacy level.

A recent bill introduced to Congress is intended to prevent product hopping, a practice that extends exclusivity and hinders the adoption of biosimilar therapies.